Dominick Colangelo Vericel Corp (VCEL) insider trading activity

Dominick Colangelo is President and CEO of Vericel Corp. Currently has a direct ownership of 260,354 shares of VCEL, which is worth approximately $10.2 Million. The most recent transaction as insider was on Feb 18, 2023, when has been sold 11,700 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 260K

17.84% 3M change

17.94% 12M change

Total Value Held $10.2 Million

Dominick Colangelo Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Feb 18 2023	BUY Exercise of conversion of derivative security	-	11,700 Added 6.22%	176,436 Common Stock
Feb 11 2023	SELL Payment of exercise price or tax liability	$102,989 $29.3 p/Share	3,515 Reduced 2.09%	164,736 Common Stock
Feb 11 2023	BUY Exercise of conversion of derivative security	-	7,500 Added 4.27%	168,251 Common Stock
Feb 06 2023	SELL Payment of exercise price or tax liability	$99,541 $30.6 p/Share	3,253 Reduced 1.98%	160,751 Common Stock
Feb 06 2023	BUY Exercise of conversion of derivative security	-	6,938 Added 4.06%	164,004 Common Stock
Jan 10 2023	SELL Open market or private sale	$1,083,517 $27.13 p/Share	39,938 Reduced 20.27%	157,066 Common Stock
Jan 10 2023	BUY Exercise of conversion of derivative security	$1,030,400 $25.8 p/Share	39,938 Added 16.86%	197,004 Common Stock
Feb 19 2022	SELL Payment of exercise price or tax liability	$135,238 $34.9 p/Share	3,875 Reduced 2.42%	156,432 Common Stock
Feb 19 2022	BUY Exercise of conversion of derivative security	-	8,937 Added 5.28%	160,307 Common Stock
Feb 11 2022	SELL Payment of exercise price or tax liability	$114,630 $35.26 p/Share	3,251 Reduced 2.1%	151,370 Common Stock
Feb 11 2022	BUY Exercise of conversion of derivative security	-	7,500 Added 4.63%	154,621 Common Stock
Feb 06 2022	SELL Payment of exercise price or tax liability	$103,392 $33.91 p/Share	3,049 Reduced 2.03%	147,121 Common Stock
Feb 06 2022	BUY Exercise of conversion of derivative security	-	6,937 Added 4.42%	150,170 Common Stock
Apr 19 2021	SELL Open market or private sale	$2,326,800 $58.17 p/Share	40,000 Reduced 21.86%	142,973 Common Stock
Apr 19 2021	BUY Exercise of conversion of derivative security	$195,125 $25.8 p/Share	7,563 Added 4.17%	173,983 Common Stock
Mar 30 2021	BUY Exercise of conversion of derivative security	$193,500 $25.8 p/Share	7,500 Added 4.11%	175,050 Common Stock
Mar 29 2021	SELL Open market or private sale	$2,043,200 $51.08 p/Share	40,000 Reduced 19.27%	167,550 Common Stock
Mar 01 2021	SELL Open market or private sale	$1,933,200 $48.33 p/Share	40,000 Reduced 16.16%	207,550 Common Stock
Mar 01 2021	BUY Exercise of conversion of derivative security	$119,091 $4.2 p/Share	28,355 Added 10.42%	243,742 Common Stock
Feb 11 2021	SELL Payment of exercise price or tax liability	$160,834 $49.23 p/Share	3,267 Reduced 1.47%	219,195 Common Stock
Feb 11 2021	BUY Exercise of conversion of derivative security	-	7,500 Added 3.26%	222,462 Common Stock
Feb 06 2021	SELL Payment of exercise price or tax liability	$145,220 $47.18 p/Share	3,078 Reduced 1.41%	214,962 Common Stock
Feb 06 2021	BUY Exercise of conversion of derivative security	-	6,938 Added 3.08%	218,040 Common Stock

Also insider at

TRVI

Trevi Therapeutics, Inc. Healthcare